AstraZeneca PLC is 127.4x more valuable than Ultragenyx Pharmaceutical Inc. by market capitalization ($286.27 B vs $2.25 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | RARE | AZN |
|---|---|---|
| Market cap | $2.25 B | $286.27 B |
| US-listed rank | #2019 | #45 |
| Revenue (latest FY) | $673.00M | - |
| Net income (latest FY) | -$575.00M | - |
| Net margin | -85.4% | - |
| SEC filings | 1,100 | 1,004 |
AstraZeneca PLC is 127.4x more valuable than Ultragenyx Pharmaceutical Inc. by market capitalization ($286.27 B vs $2.25 B).
Full pages: Ultragenyx Pharmaceutical Inc. and AstraZeneca PLC, or browse the full rankings.